This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Haihe Biopharma Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovator Spotlight: Yanyan Shen - Advances in Indolizine Compounds
Introduction: Yanyan Shen is a prominent inventor based in Shanghai, China, with notable contributions to the field of medicinal chemistry. With one patent to his name, Shen has focused on developing compounds that hold significant potential for therapeutic applications, particularly in combating tumors and autoimmune diseases.
Latest Patents: Shen's latest patent, titled "Indolizine compounds, preparation method and use thereof," introduces an indolizine compound represented by a specific formula or its pharmaceutically acceptable salt. This innovative compound is recognized for its inhibitory effects on wild-type and mutant EZH2 or EZH1, positioning it as a promising candidate for the development of new drugs aimed at treating various cancers and autoimmune disorders.
Career Highlights: Yanyan Shen has established himself as a key figure in the biopharmaceutical industry through his work at Haihe Biopharma Co., Ltd. His research and development efforts have significantly contributed to advancing the understanding and application of indolizine compounds. With a focus on innovative drug development, Shen's work continues to shape the future of therapeutic solutions in the medical field.
Collaborations: In his quest for innovation, Yanyan Shen collaborates with distinguished colleagues such as Xuxing Chen and Yi Chen. These partnerships facilitate a dynamic exchange of ideas and expertise, further enhancing the potential of the research conducted at Haihe Biopharma Co., Ltd. Together, they strive to achieve breakthroughs in biopharmaceutical developments.
Conclusion: Yanyan Shen is an inspiring example of the impact an inventor can have within the field of medicine and pharmaceuticals. With his pioneering work on indolizine compounds, he is paving the way for new treatments that could improve the lives of many individuals. As biopharmaceutical advancements continue to evolve, Shen's contributions will undoubtedly play a vital role in shaping the future of drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile